[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341332-105":59,"doc-detail-341332-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","germline-mutations-of-breast-cancer-susceptibility-genes-through-expanded-genetic-analysis-in-unselected-colombian-patients","Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients","","Breast cancer is the leading cause of cancer death among women in Colombia and worldwide, yet evidence on germline mutations in unselected Latin-American patients remains limited. A study of 400 women with unselected breast cancer used whole exome sequencing to profile ten risk genes and multiplex ligation-dependent probe amplification to detect large rearrangements in BRCA1/2. A recurrent intronic ATM variant was functionally tested. Pathogenic/likely pathogenic variants were found across multiple genes, supporting population-based molecular testing and early detection strategies.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/germline-mutations-of-breast-cancer-susceptibility-genes-through-expanded-genetic-analysis-in-unselected-colombian-patients/341332/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/germline-mutations-of-breast-cancer-susceptibility-genes-through-expanded-genetic-analysis-in-unselected-colombian-patients/341332.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main objective of the study in Colombian unselected patients?","Question",{"text":112,"@type":113},"To determine the genomic profile of previously unreported pathogenic/likely pathogenic germline variants using expanded genetic analysis in unselected Colombian breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genetic technologies were used to analyze the patients?",{"text":117,"@type":113},"Whole exome sequencing was used to analyze ten breast cancer risk genes, multiplex ligation-dependent probe amplification (MLPA) was used to identify large genomic rearrangements in BRCA1/2, and a minigene assay was performed for a recurrent intronic variant functional evaluation.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings were reported about the frequency of pathogenic/likely pathogenic variants?",{"text":121,"@type":113},"Pathogenic/likely pathogenic germline variants were identified in several genes, with BRCA2 showing the highest frequency, and overall P/LP variants accounting for 6% of the analyzed population; no large genomic rearrangements were detected.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the functional validation clarify the effect of the recurrent ATM intronic variant?",{"text":125,"@type":113},"Functional validation indicated a splicing alteration likely affecting the protein’s structure by modifying the Pincer domain.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},341332,1790113087,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Sierra‑Díaz etal. Human Genomics (2024) 18:68 [https://doi.org/10.1](https://doi.org/10.1) 186/s40246‑024‑00623‑7  \nHuman Genomics  \n RESEARCH Open Access  \nGermline mutations of breast cancer  \nsusceptibility genes through expanded genetic analysis in unselected Colombian patients  \nDiana Carolina Sierra‑Díaz1, Adrien Morel 1, Dora Janeth Fonseca‑Mendoza 1, Nora Contreras Bravo 1, Nicolas Molano‑Gonzalez9, Mariana Borras2, Isabel Munevar2, Mauricio Lema3, Henry Idrobo4, Daniela Trujillo4, Norma Serrano5, Ana Isabel Orduz5, Diego Lopera6, Jaime González6, Gustavo Rojas6,13, Paula Londono‑De Los Ríos6,13, Ray Manneh7, Rodrigo Cabrera1,11, Wilson Rubiano8, Jairo de la Peña8, María Catalina Quintero12, William Mantilla2,10 and Carlos M. Restrepo 1*  \nAbstract  \nBackground In Colombia and worldwide, breast cancer (BC) is the most frequently diagnosed neoplasia  \nand the leading cause of death from cancer among women. Studies predominantly involve hereditary and familial cases, demonstrating a gap in the literature regarding the identification of germline mutations in unselected patients from Latin‑America. Identification of pathogenic/likely pathogenic (P/LP) variants is important for shaping national genetic analysis policies, genetic counseling, and early detection strategies. The present study included 400 women with unselected breast cancer (BC), in whom we analyzed ten genes, using Whole Exome Sequencing (WES), know to confer risk for BC, with the aim of determining the genomic profile of previously unreported P/LP variants in the affected population. Additionally, Multiplex Ligation‑dependent Probe Amplification (MLPA) was performed to iden‑ tify Large Genomic Rearrangements (LGRs) in the BRCA1/2 genes. To ascertain the functional impact of a recurrent intronic variant (ATM c.5496 + 2_5496 + 5delTAAG), a minigene assay was conducted.  \nResults We ascertained the frequency of P/LP germline variants in BRCA2 (2 . 5%), ATM (1 . 25%), BRCA1 (0 . 75%), PALB2 (0 . 50%), CHEK2 (0 . 50%), BARD1 (0 . 25%), and RAD51D (0 . 25%) genes in the population of study. P/LP variants account for 6% of the total population analyzed. No LGRs were detected in our study. We identified 1. 75% of recurrent variants in BRCA2 and ATM genes. One of them corresponds to theATM c.5496 + 2_5496 + 5delTAAG. Functional validation of this variant demonstrated a splicing alteration probably modifying the Pincer domain and subsequent protein structure.  \nConclusion This study described for the first time the genomic profile often risk genes in Colombian women with unselected BC. Our findings underscore the significance of population‑based research, advocating the consid‑ eration of molecular testing in all women with cancer.  \nKeywords Unselected breast cancer, Whole exome sequencing, Pathogenic germline variants, Minigene assay  \n*Correspondence:  \nCarlos M. Restrepo  \n[carlos. restrepo@urosario.edu.co](carlos. restrepo@urosario.edu.co)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication wai","cbCaiuBvL9McDdb4","https://ap.wps.com/l/cbCaiuBvL9McDdb4","pdf",2070969,14,"English","# Abstract\n# Background\n# Results\n# Conclusion","[{\"question\":\"What was the main objective of the study in Colombian unselected patients?\",\"answer\":\"To determine the genomic profile of previously unreported pathogenic/likely pathogenic germline variants using expanded genetic analysis in unselected Colombian breast cancer patients.\"},{\"question\":\"Which genetic technologies were used to analyze the patients?\",\"answer\":\"Whole exome sequencing was used to analyze ten breast cancer risk genes, multiplex ligation-dependent probe amplification (MLPA) was used to identify large genomic rearrangements in BRCA1/2, and a minigene assay was performed for a recurrent intronic variant functional evaluation.\"},{\"question\":\"What key findings were reported about the frequency of pathogenic/likely pathogenic variants?\",\"answer\":\"Pathogenic/likely pathogenic germline variants were identified in several genes, with BRCA2 showing the highest frequency, and overall P/LP variants accounting for 6% of the analyzed population; no large genomic rearrangements were detected.\"},{\"question\":\"How did the functional validation clarify the effect of the recurrent ATM intronic variant?\",\"answer\":\"Functional validation indicated a splicing alteration likely affecting the protein’s structure by modifying the Pincer domain.\"}]","Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients | PDF",1790041570,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2155f78c626b2c89fa9c86e11633a45.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c383e541563c88b414b03f10ab6417ec.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76dbc9395e136eaeff0f747f7471ae3b.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f4484c134030a01e1cbadac9d5b8f70.webp",980,1301]